MDxHealth SA (MDXH.BR)
-Brussels 2.03 
0.02(0.98%) 10:20AM EDT
| Prev Close: | 2.05 |
|---|
| Open: | 2.04 |
|---|
| Bid: | 2.02 |
|---|
| Ask: | 2.04 |
|---|
| 1y Target Est: | 3.50 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.02 - 2.05 |
|---|
| 52wk Range: | 1.30 - 2.77 |
|---|
| Volume: | 37,888 |
|---|
| Avg Vol (3m): | 36,657 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Q1 2013 MDxHealth SA Earnings Release - Time Not SuppliedCCBN(Tue, May 7)
- MDxHealth Q1 revenues rise by half as new test sales pick upat Reuters(Tue, May 7)
- MDxHealth says U.S. meeting confirms test strengthat Reuters(Mon, Apr 22)
- MDxHealth Announces Publication of the Clinical Utility of Combining Genetics and Epigenetics to Improve Management of Prostate cancerThomson Reuters ONE(Wed, Apr 3)
- MDxHealth Receives ISO 9001:2008 Certification for its Commercial U.S. Based CLIA LaboratoryThomson Reuters ONE(Tue, Apr 2)
- MDxHealth and Ghent University Aim to Establish Sensitive and Cost-Effective Industry Standard for Genome-wide DNA methylation Profiling ToolsThomson Reuters ONE(Tue, Mar 19)
- Q4 2012 MDxHealth SA Earnings Release - Time Not SuppliedCCBN(Thu, Feb 28)
- MDxHealth Reports Fourth Quarter and Fiscal Year 2012 ResultsThomson Reuters ONE(Thu, Feb 28)
- MDxHealth Announces Publication of Health Economic Analysis Demonstrating Cost-Savings of ConfirmMDx for Prostate CancerThomson Reuters ONE(Thu, Feb 14)
- Prostate-Cancer Test May Reduce Repeat Biopsies: Studyat Bloomberg(Tue, Oct 2)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
No business summary available forMDXH.BR.